아스타

246720KOSDAQ의료용품 및 기타 의약 관련제품 제조업

38.0 / 100

Reference Date: 2026-04-13

Financial Score7.5 / 40

News Sentiment12.5 / 25

Momentum5.0 / 20

Disclosure13.0 / 15

AI Analysis: the high debt ratio poses financial risk, PBR raises overvaluation concerns. Plunged 18.3% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Asta is a technology-driven company established in 2006, specializing in the development, production, and sale of MALDI-TOF mass spectrometers and related consumables. The company has expanded into medical microbiology diagnostics and industrial applications, launching high-resolution LDI-TOF imaging systems and semiconductor process inspection tools like GM-TOF in 2024. It is also focusing on global market expansion through cloud-based diagnostic platforms and technology licensing.

Number of Employees

38people

Average Salary

65.3M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 19.894.0Point

PBR

10.78Industry Average 1.620.0Point

6.7x industry avg (risky)

ROE

-49.41Industry Average -4.893.5Point

10.1x industry avg (excellent)

Debt Ratio

29.87Industry Average 8.880.0Point

3.4x industry avg (risky)

Trend 2023~20250.0 / 10 points

Revenue Growth Rate

0.0 / 3

Avg ▼7.8% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼6.0% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -62.1% (improving, 2yr)

Detailed News Sentiment

2 totalPositive 0Neutral 1Negative 1Average Sentiment Score 50

Negative
거래소, 아스타에 감사의견 비적정설 조회공시 요구
한국거래소 코스닥시장본부가 아스타에 감사의견 비적정설에 대한 조회공시를 요구했다는 소식입니다.
Neutral
아스타, 30억원 규모 자기전환사채 만기 전 취득
아스타가 사채권자의 조기상환청구권 행사로 30억원 규모의 제1회차 무기명식 이권부 무보증 사모 전환사채를 만기 전 취득했다는 소식입니다.

Detailed Momentum

52-week position3.0Point

52w lower range (29%)

Current 6,070Won52-week high 10,98052-week low 4,015

1-month return0.0Point

1m -18.30% (strong drop)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

17 totalPositive 3Neutral 13Negative 1

Neutral[기재정정]정기주주총회결과 (연기회)2026-04-07
Neutral[기재정정]주식등의대량보유상황보고서(일반)2026-04-02
Neutral[기재정정]사업보고서 (2025.12)2026-03-31
Neutral주식등의대량보유상황보고서(일반)2026-03-31
Positive[기재정정]최대주주변경을수반하는주식담보제공계약체결2026-03-30